We would like to thank our exhibitors and sponsors for sponsoring this meeting. This includes pharmaceutical companies including Axunio UK and Pierre Fabre Ltd. They have had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the sponsored symposia presentations.

Event Schedule

Tuesday, May 19, 2026
9:35 AM - 10:25 AM
Chair’s opening remarks followed by: Hypertension updates: from guidelines to consultation
  • Accurate diagnosis and monitoring: ambulatory vs home vs clinic measurements
  • Risk stratification and individualised treatment pathways
  • Managing resistant hypertension and common comorbidities
  • Lifestyle interventions and adherence strategies that work in everyday practice
 
 
10:40 AM - 11:25 AM
FreeDM2 : redefining approaches to type 2 diabetes care
 

Sponsored by:

11:40 AM - 12:25 PM
From practice to neighbourhood: the 5 shifts PCNs can't afford to ignore
  • How is the Neighbourhood different - looking at the similarities but differences of being a PCN versus a Neighbourhood provider under the new framework
  • The five shifts that cannot be ignored — how you recall, when you recall, what you can see, who you're missing, and what you can prove
  • The direct impact of Practices that are making this shift now — real data, real financial impact, real operational impact
     

Sponsored by Suvera

12:40 PM - 1:25 PM
CKD clinical conundrums
  • Evidence
  • Risk stratification
  • Kidney protective therapies
 
 
1:40 PM - 2:25 PM
Rethinking hyperhidrosis in general practice: from diagnosis to new management strategies
  • Recognise the clinical features and impact of primary hyperhidrosis on patient wellbeing.
  • Apply practical, evidence-based management strategies for hyperhidrosis, including lifestyle advice, topical and systemic treatments, referral criteria, and when to consider newer therapeutic options.
  • Describe current and emerging treatment options for primary hyperhidrosis, and understand how new therapies may be incorporated into primary care management

This is an Axunio UK initiated and sponsored promotional symposium

2:40 PM - 3:25 PM
An overview of cryotherapy/cryosurgery treatments in primary care for the removal of benign skin lesions
  • An overview of the principles and theory of cryotherapy/cryosurgery practice 
  • The clinical indications and applications of cryotherapy treatments in primary care, specifically for the removal of benign (non cancerous) skin lesions in primary care. 
  • The process of obtaining informed consent for a patient in whom cryotherapy treatment is intended. 
  • An overview of the various portable and handheld cryotherapy devices, including both Cryosprays and CryoProbes, which are currently available for use in the UK
     
 
 
3:40 PM - 4:25 PM
Management of type 2 diabetes: the NICE way to do it
  • Understand NICE's approach to managing Type 2 diabetes
  • Recognise how treatment choices are tailored based on comorbidities , hypoglycemia risk , weight and age 
  • The importance of ongoing monitoring and complication prevention 
 
 
Wednesday, May 20, 2026
9:35 AM - 10:25 AM
Chair’s opening remarks followed by: Practical use of emollients in chronic skin disease management
 
 
 
10:40 AM - 11:25 AM
Identification and management of Actinic Keratosis: a practical guide
  • Why does AK matter
  • Differentiation of AK from similar lesions
  • Current treatment landscape
     

This promotional webinar has been organised and funded by Pierre Fabre Ltd and is intended for UK healthcare professionals only

11:40 AM - 12:25 PM
Glucose patterns and prediabetes: spotting signs early with CGMs

Attendees will be able to:

  • Understand how real time CGM data can reveal early glucose variability that is not captured through traditional testing
  • Recognise the value of CGMs in improving patient awareness, motivation and engagement with dietary change
  • Identify common glucose patterns linked to symptoms such as tiredness, cravings, sleep issues and mood dips
  • Apply CGM insights to guide personalised lifestyle adjustments within primary care
  • Integrate CGMs into existing prediabetes pathways to support early intervention and metabolic risk reduction

This educational session has been sponsored and organised by Abbott and the speaker is presenting on behalf of Abbott. The speaker has received an honorarium for this presentation.  

12:40 PM - 1:25 PM
Lifestyle as treatment: primary care approaches to metabolic and cardiovascular disease
  • Physical activity, nutrition, sleep and stress management
  • Motivational techniques and personalised care plans that work in consultations
  • Achieving sustainable improvements in weight, blood pressure, lipids, and glycaemic control
     
 
 
2:00 PM - 2:45 PM
Supporting mental health in general practice: evidence-based approaches for GPs
 
 
 
3:00 PM - 4:00 PM
Managing acne in primary care in the era of antimicrobial stewardship
 
 
 
4:00 PM
Conference ends
 
 
 
 

Speakers